Position in LGND
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$16,052,059
+$2,964,634 QoQ
Shares Held
80,401
+16.2% QoQ
Ownership
0.401%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FIRST TRUST ADVISORS LP holds $2,375,392,616 across 80 Biotechnology names. LGND ranks #26 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
346,855 | $267,994,047 | |
| 2 | INCY |
Incyte Corp
|
1,500,792 | $141,254,543 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
306,461 | $136,847,094 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
382,701 | $126,624,279 | |
| 5 | MRNA |
Moderna, Inc.
|
2,392,693 | $121,548,804 | |
| 6 | EXEL |
Exelixis, Inc.
|
2,534,992 | $108,725,806 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
577,479 | $97,605,500 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
1,482,340 | $95,803,634 |
All Filings in LGND
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,052,059 | 80,401 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $13,087,425 | 69,220 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $9,156,012 | 51,688 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,552,131 | 48,840 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,392,867 | 32,270 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,570,880 | 33,326 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $3,536,880 | 35,337 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,682,417 | 31,835 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,514,997 | 20,725 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,515,318 | 21,217 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,075,863 | 17,955 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $1,247,209 | 16,955 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $285,770 | 4,278 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $590,844 | 10,999 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $769,862 | 13,832 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $557,818 | 7,949 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $411,443 | 4,270 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,090,658 | 12,549 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,629,201 | 32,126 | Shares | Sole | 2021-10-12 | |
| 2020-12-31 | $377,450 | 6,084 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,152,759 | 19,386 | Shares | Sole | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||